bg
A

Annexon (ANNX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Annexon (ANNX)

Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more

  • USD5.98
  • USD6.07
  • USD5.86
  • USD8.40
  • 34.90%
  • --
  • 510.21k
  • 2.17M
  • 557M
  • 1.57
  • 28.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.